Table 2.

Genotype and allelic frequencies of LAPTM4B gene polymorphism among prostate cancer patients and controls.

LAPTM4B genotype	Cases n (%)	Controls n (%)	OR (95%CI)	p-value
Co-dominant
LAPTM4B *1/1	102 (60.7)	79 (44.9)	1.00	—
LAPTM4B *1/2	55 (32.8)	87 (49.4)	0.49 (0.31–0.77)	0.002
LAPTM4B *2/2	11 (6.5)	10 (5.7)	0.85 (0.34–2.11)	0.817
Dominant
LAPTM4B *1/1	102 (60.7)	79 (44.9)	1.00	—
LAPTM4B *1/2+*2/2	66 (39.3)	97 (55.1)	0.53 (0.34–0.81)	0.004
Recessive
LAPTM4B *1/1+*1/2	157 (93.5)	166 (94.3)	1.0	—
LAPTM4B *2/2	11 (6.5)	10 (5.7)	1.16 (0.48–2.82)	0.823
Allele
LAPTM4B *1	259 (77.1)	245 (69.6)	1.00	—
LAPTM4B *2	77 (22.9)	107 (30.4)	0.68 (0.48–0.96)	0.031